Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xiamen Hemont Biotechnology is a high-tech enterprise headquartered in Xiamen, China, focusing on the research, development, and manufacturing of in vitro diagnostic (IVD) products. The company specializes in molecular diagnostics and point-of-care testing (POCT) solutions, particularly for infectious diseases, oncology, and genetic screening. Their product line includes automated nucleic acid extraction instruments and a variety of detection kits for pathogens such as SARS-CoV-2, HPV, and Mycobacterium tuberculosis. By integrating advanced biotechnology with clinical needs, Hemont provides comprehensive diagnostic solutions to hospitals, disease control centers, and research institutions worldwide. The company maintains rigorous quality standards, holding ISO 13485 certification and CE marks for its core diagnostic portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xiamen Hemont Biotechnology.